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he protective antigen (PA) of the anthrax toxin binds
to a cell surface receptor and thereby allows lethal
factor (LF) to be taken up and exert its toxic effect in
the cytoplasm. Here, we report that clustering of the anthrax
toxin receptor (ATR) with heptameric PA or with an antibody
sandwich causes its association to specialized cholesterol
and glycosphingolipid-rich microdomains of the plasma
membrane (lipid rafts). We ﬁnd that although endocytosis
of ATR is slow, clustering it into rafts either via PA heptamer-
ization or using an antibody sandwich is necessary and
sufﬁcient to trigger efﬁcient internalization and allow delivery
T
 
of LF to the cytoplasm. Importantly, altering raft integrity
using drugs prevented LF delivery and cleavage of cytosolic
MAPK kinases, suggesting that lipid rafts could be therapeutic
targets for drugs against anthrax. Moreover, we show that
 
internalization of PA is dynamin and Eps15 dependent,
indicating that the clathrin-dependent pathway is the major
route of anthrax toxin entry into the cell. The present work
illustrates that although the physiological role of the ATR is
unknown, its trafﬁcking properties, i.e., slow endocytosis as
a monomer and rapid clathrin-mediated uptake on clustering,
make it an ideal anthrax toxin receptor.
 
Introduction
 
Anthrax toxin is one of the two dominant virulence factors
produced by 
 
Bacillus anthracis
 
 (Leppla, 1991). The toxin is
composed of three subunits; edema factor (EF),* lethal
factor (LF), and protective antigen (PA). EF is a calmodulin-
dependent adenylate cyclase that elevates intracellular levels
of cAMP (Leppla, 1982). LF is a metalloprotease that targets
all MAPK kinases (Duesbery et al., 1998; Vitale et al., 1998)
with the exception of MEK5 (Vitale et al., 2000), and is
responsible for macrophage cell death (Chaudry et al., 2002;
Mourez et al., 2002). Although LF and EF are ultimately
responsible for the toxicity of the anthrax toxin, these two
subunits cannot exert their effects in the absence of PA because
they are unable to reach their cytoplasmic targets. Their
recognition of the target cell and transport from the extra-
cellular space to the cytoplasm absolutely requires PA.
PA is an 83-kD protein (PA83) that binds to a widely
expressed, 368 amino acid, type 1 membrane protein
termed anthrax toxin receptor (ATR; Bradley et al., 2001).
Receptor-bound PA is then cleaved by members of the furin
 
family of proteases, causing release of an NH
 
2
 
-terminal 20-kD
fragment and leaving the COOH-terminal 63-kD moiety
(PA63) bound to ATR. It is important to stress that furin
cleavage occurs at the cell surface, even though this enzyme
is more abundant intracellularly and in particular, in the
TGN (Chaudry et al., 2002; Mourez et al., 2002). Unlike
PA83, PA63 can oligomerize to form ring-shaped heptamers
(Petosa et al., 1997). Interaction of LF and EF with PA63
occurs at the cell surface after heptamerization has occurred
(Singh et al., 1994; Mogridge et al., 2001; Cunningham et
al., 2002). The complex of PA63 with LF and/or EF is then
internalized and transported to endosomes where the low
pH triggers membrane insertion of the PA63 heptamer and
channel formation (Milne et al., 1994; Mourez et al., 2002).
Delivery of EF and LF to the cytosol is concomitant with
PA63 channel formation and may involve passage of these
proteins through the channel. Once in the cytoplasm, LF
and EF modify their respective targets.
A crucial step in the mode of action of anthrax toxin that
has received surprisingly little attention is the initial entry.
Interestingly, PA63 is endocytosed, whereas the precursor
PA83 remains at the cell surface (Beauregard et al., 2000).
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Here, we have analyzed the mechanism that triggers the spe-
cific cellular uptake of PA63 and thereby of the enzymatic
units, LF and EF.
 
Results and discussion
 
We investigated whether the selective uptake of PA63, and
not of PA83, was due to a change in surface distribution on
conversion of PA83 to PA63. The similarity between the
structure and the mode of action of PA and that of certain
bacterial pore-forming toxins such as aerolysin (Abrami et
al., 2000) prompted us to determine whether PA63 was as-
sociated with raftlike lipid microdomains of the plasma
membrane. These domains are thought to form through lat-
eral movement and assembly of cholesterol and glycosphin-
golipids. A specific subclass of rafts form flasklike invagina-
tions at the plasma membrane and are then called caveolae
(Simons and Ikonen, 1997; Brown and London, 1998).
Rafts act as surface platforms in signal transduction, choles-
terol homeostasis, and endocytosis (Brown and London,
1998; Simons and Toomre, 2000). Lipid rafts have also
been implicated in various infectious processes (Fivaz et al.,
1999), and in particular, were shown to favor heptameriza-
tion of the pore-forming toxin aerolysin (Abrami and van
der Goot, 1999) via mechanisms that could well apply to
PA. One biochemical characteristic of rafts is their resistance
to nonionic detergents at 4
 
 
 
C, which allows their purifica-
tion on density gradients. Native, full-size PA83 was associ-
ated with detergent-soluble domains of the plasma mem-
brane (Fig. 1 A) in agreement with previous observations
(Beauregard et al., 1999), as was a variant of PA mutated in
the consensus furin cleavage site (PA
 
SNKE
 
; Gordon et al.,
1995). In contrast, PA63 (which can be obtained either in
vitro by trypsin cleavage or in vivo by cell surface furin pro-
cessing) was almost exclusively associated with detergent-
resistant membranes (DRMs; Fig. 1 A). To confirm that the
presence of PA63 in more buoyant, upper fractions of the
gradient, is indeed due to its association with lipid rafts, we
investigated whether the distribution of PA63 was altered by
removal of plasma membrane cholesterol using 
 
 
 
-methyl cy-
clodextrin (
 
 
 
-MCD) or sequestration of cholesterol using
filipin (Simons and Toomre, 2000). As shown in Fig. 1 B,
PA63 was partially (
 
 
 
-MCD) or completely (filipin) redis-
tributed to the bottom of the gradient, in a manner similar
to that of the normally raft-associated protein flotillin-1
(Bickel et al., 1997), but in contrast to the caveolar protein
caveolin-1 (Kurzchalia and Parton, 1999). Because rafts are
also rich in sphingomyelin, we analyzed whether reduction
of sphingomyelin levels would affect the surface distribution
of PA63. In sphingomyelin-deficient mutant CHO cells
(Hanada et al., 1998), PA63 was no longer associated with
DRMs (Fig. 1 B). Flotillin-1 was also partially redistributed
to detergent-soluble fractions, in contrast to caveolin-1,
which remained at the top of the gradient. Thus, PA63 is as-
sociated with noncaveolar cholesterol and sphingolipid-rich
domains of the plasma membrane.
Figure 1. Proteolytic processing of PA 
triggers partitioning of the anthrax toxin 
into lipid rafts. (A) Wild-type CHO cells 
were incubated for 1 h at 4 C with 500 
ng/ml of either a mixture of native and 
trypsin-nicked PA83 (PA63), or PA
SNKE. 
DRMs were prepared and analyzed 
by Western blotting against PA and 
caveolin-1. The load (L) corresponds to 
1/10 of the total material on the gradient. 
(B) Wild-type, sphingomyelin-deficient 
(CHO SPB), and recomplemented (CHO 
SPB(lcb1)) CHO cells were treated or not 
with  -MCD or filipin, then incubated 
with 500 ng/ml PA83 for 1 h at 4 C 
followed by 30 min at 37 C. DRMs were 
prepared and fractions were probed 
for the presence of PA, caveolin-1, and 
flotillin-1 by Western blotting. (C) ATR-
deficient CHO cells were stably 
transfected with human ATR having an 
HA-tag at the COOH terminus. DRMs 
were prepared and fractions were probed 
using a biotinylated anti-HA antibody. 
The two upper bands are endogenous 
biotinylated CHO cell proteins recognized 
by the streptavidin-HRP, even in cells not 
expressing ATR-HA. (D) CHO cells were 
incubated with 500 ng/ml of either trypsin-
nicked PA83 or of PA
SNKE for 1 h at 4 C 
followed by 30 min at 37 C, washed at 
4 C, and further incubated with 1  g/ml 
LF for 1 h at 4 C before preparation of 
DRMs. Fractions were analyzed by 
Western blot with anti-LF pAb.T
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The fact that PA83, which is the form of the toxin that
initially encounters the cell, was not raft-associated sug-
gested that the PA receptor (ATR) is not itself a raft resident
protein. Because antibodies against ATR are not available,
we stably expressed a COOH-terminal HA epitope–tagged
version of ATR (ATR-HA) in CHO PR230, a spontaneous
ATR-deficient mutant derived from CHO-K1 cells (Liu and
Leppla, 2003). As predicted, the receptor was solubilized by
the detergent (Fig. 1 C), indicating that ATR has little, if
any, affinity for rafts. Therefore, although aerolysin and
other toxins owe their rafts association to the fact that their
receptors reside in these microdomains (Abrami and van der
Goot, 1999), PA appears to force the raft association of its
receptor that is normally in the glycerophospholipidic, non-
raft region of the membrane.
The fact that only the mature PA63 form can promote
raft association suggests that it might be heptamerization of
PA63 that leads to clustering of ATR, which in turn would
increase raft partitioning of the receptor. If so, PA63 hep-
tamers should be associated with cell surface rafts.
To probe for cell surface heptamers, we measured binding
of LF to cells treated with PA63 at 4
 
 
 
C because LF interacts
with heptameric, but not with monomeric PA63 (Mogridge
et al., 2001; cell surface PA63 heptamers cannot be revealed
by SDS-PAGE because they dissociate in SDS). As shown in
Fig. 1 D, surface-bound LF was indeed associated with
DRMs of PA63-treated cells (but was not detectable on cells
incubated with PA
 
SNKE
 
), indicating that heptameric PA63
and its ligand LF are predominantly present in lipid rafts.
Our hypothesis also predicts that clustering ATR by
means other than PA heptamerization, for example by cross-
linking ATR using a sandwich of primary and secondary an-
tibodies (Harder et al., 1998), should lead to raft associa-
tion. Not having anti-ATR antibodies, ATR was labeled
with PA83, which cannot heptamerize unless processed, and
thus clustering at 4
 
 
 
C was induced with antibodies against
PA. Whether a monoclonal or a polyclonal antibody was
used, the clustered PA83 was predominantly present in
DRMs, in contrast to the nonclustered PA83 (Fig. 2 A).
That antibody clustering modified the surface distribution
of ATR was confirmed by fluorescence microscopy. As
shown in Fig. 2 B, a very punctate and intense signal was ob-
served on cross-linking, whereas on cells that had been fixed
before the addition of antibodies, the staining was weaker
and more diffuse (note that some punctate structures can be
observed that could well be due to cross-linking after PFA
fixation as previously observed for GPI-anchored proteins;
Maxfield and Mayor, 1997). The antibody-induced DRM
association was cholesterol-dependent, as shown by the sen-
sitivity to filipin and 
 
 
 
-MCD (Fig. 2 C), strengthening the
notion that lipid rafts control this process. Importantly,
clustering of PA83 also led to the redistribution of a popula-
tion of ATR-HA to DRMs (Fig. 2 D ; the majority of ATR-
HA remains in detergent soluble fractions because of the
vast excess of receptor with respect to PA, and because intra-
cellular receptors are unavailable for PA63 binding). We fur-
ther confirmed the raft association of clustered PA83 by cel-
lular localization studies. As a typical raft marker, we used
antibody-clustered GPI-anchored proteins (Harder et al.,
1998) that were labeled using an inactive mutant of aero-
lysin, a specific probe for this class of proteins (Fivaz et al.,
2002). As shown in Fig. 2 E (arrows), we found strong colo-
calization with GPI-anchored proteins not only for PA63, as
expected, but also for clustered wild-type PA83 and PA
 
SNKE
 
,
consistent with our biochemical analysis. However, we
could not see any significant colocalization at the cell surface
of clustered PA83 with caveolin-1 (Fig. 2 F), strengthening
the notion that PA associates with noncaveolar rafts (Fig. 1).
The above experiments show that clustering of ATR, either
by PA63 heptamerization or by antibody cross-linking, pro-
motes its partitioning into rafts (Fig. 2 G).
Next, we investigated whether ATR clustering is also a
trigger for internalization. Again, we made use of the PA
variant that cannot be processed by furin because such mu-
tants remain at the cell surface (Beauregard et al., 2000), and
investigated whether antibody clustering would promote in-
ternalization. Cells were incubated with PA
 
SNKE
 
 at 4
 
 
 
C, and
a sandwich of primary and secondary antibodies was then
added (Fig. 3 A, middle and bottom rows) or not (Fig. 3 A,
top row) at 4
 
 
 
C. Cells were then shifted to 37
 
 
 
C to allow in-
ternalization (Fig. 3 A, top and middle rows) or kept on ice
(Fig. 3 A, bottom row). Control cells (PA
 
SNKE
 
 with no anti-
bodies; Fig. 3 A, top row) were shifted back to 4
 
 
 
C and were
then treated with primary and secondary antibodies. Finally,
cells were submitted or not to an acid wash in order to re-
move surface-bound antibodies and to reveal only the intra-
cellular PA
 
SNKE
 
. Intracellular PA
 
SNKE
 
 could only be detected
when antibody cross-linking was performed before the inter-
nalization step (Fig. 3 A, middle row), demonstrating that
clustering of PA83 is necessary and sufficient to promote its
cellular uptake. When cells were treated with 
 
 
 
-MCD be-
fore PA and antibody addition, intracellular accumulation
was significantly reduced (Fig. 3 B).
To evaluate the physiological relevance of the role of rafts
in the delivery of PA to endosomes, we measured the effect
of cholesterol depletion on the appearance of the SDS-resis-
tant PA63 heptamer because this form only appears in an
acidic environment. As shown in Fig. 4 A, formation of the
membrane-inserted SDS-resistant heptamer was strongly de-
layed on 
 
 
 
-MCD treatment.
Finally, to emphasize the physiological relevance of the as-
sociation of the PA63–LF complex with lipid rafts, we ana-
lyzed the effects of 
 
 
 
-MCD on the kinetics of cleavage of
MEK1, one of the intracellular MAPK kinases targeted by
LF. Processing of MEK1 by LF can be easily followed by
Western blotting because it is accompanied by the loss of
NH
 
2
 
-terminal epitopes due to the removal of seven amino
acids form the NH
 
2
 
 terminus (Duesbery et al., 1998). In
control cells, NH
 
2
 
-terminal cleavage of MEK1 was observed
with time, whereas total MEK1, detected with an anti-
COOH-terminal antibody, remained constant (Fig. 4 B). In
marked contrast, MEK1 remained intact within the time
frame studied in 
 
 
 
-MCD–treated cells (Fig. 4 B). We con-
firmed, as a control, that similar amounts of LF were associ-
ated with control and 
 
 
 
-MCD–treated cells (Fig. 4 B).
Thus, LF cannot reach its intracellular target if lipid rafts are
disrupted with the drug.
The fact that internalization of the ATR was both ligand-
triggered and raft-dependent raised the possibility that cave-
olin-dependent endocytosis might be involved (PelkmansT
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and Helenius, 2002). However, the observation that PA63
and caveolin-1 showed different behaviors on cells at 4
 
 
 
C
(Fig. 1 B and Fig. 2 F) and the fact that caveosomes are neu-
tral and do not appear to communicate with any acidic or-
ganelle (Pelkmans and Helenius, 2002; knowing that the
PA63 heptamer requires an acidic pH for membrane inser-
Figure 2. Antibody cross-linking promotes raft association of PA83 in a cholesterol-dependent manner. (A) CHO cells were incubated at 
4 C with 500 ng/ml PA83 for 20 min. Surface PA was then clustered by an antibody sandwich at 4 C. DRMs were prepared and fractions 
were probed for PA by Western blotting. (B) CHO cells were treated for 1 h at 4 C with 500 ng/ml PA83, and then were either fixed with PFA 
followed by incubation with primary and secondary antibodies to detect PA (Fix Xlink), or incubated for 30 min at 4 C with rabbit polyclonal 
anti-PA, or for 30 min at 4 C with the secondary antibodies and then fixed (Xlink Fix). Bar, 10  m. (C) CHO cells were treated or not with 
 -MCD or filipin, then treated as in A. DRMs were prepared and fractions were probed for the presence of PA as in A. (D) ATR-HA–expressing 
CHO cells were incubated or not with 500 ng/ml PA83 for 20 min and submitted to antibody (polyclonal) clustering as in A. DRMs were 
prepared and fractions were probed for the presence of ATR-HA by HA antibodies. (E) CHO cells were treated for 1 h at 4 C with 500 ng/ml 
PA (either native PA83, trypsin nicked PA83, or PA
SNKE) and 500 ng/ml of an inactive aerolysin mutant (ASSP), a monovalent probe for GPI-
anchored proteins. Cells were then successively incubated for 30 min at 4 C with rabbit polyclonal anti-PA and chicken polyclonal anti-aerolysin 
antibodies for 30 min at 4 C with corresponding fluorescent secondary antibodies. Cells were fixed and visualized. For ease of analysis, only 
a small region of the plasma membrane is shown for each condition. Bar, 2.5  m. (F) CHO cells were treated as in B (Xlink Fix), and were 
then permeabilized with saponin and double labeled for the presence of caveolin-1. Bar, 5  m. (G) Schematic behavior of ATR at the cell 
surface. ATR and the ATR–PA83 complex are present in the glycerophospholipid area of the plasma membrane. On clustering of ATR either 
via heptamerization of PA63 or by anti-body cross-linking, the transmembrane protein is stabilized within lipid rafts.T
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tion) argue against a caveolar mediated uptake. To clarify
this issue, we investigated whether expression of a dominant-
negative mutant of caveolin-1, namely caveolin-1 with the
GFP fused to its NH
 
2
 
 terminus (GFP-Cav1; Pelkmans et al.,
2001), would affect anthrax toxin entry. The kinetics of ap-
pearance of the SDS-resistant PA63 heptamer (Fig. 5 A) as
 
well as the kinetics of MEK1 cleavage (unpublished data)
were very similar in control and GFP-Cav1–expressing cells.
Also, we found little colocalization between 30-min inter-
nalized antibody-clustered PA83 and caveolin-1-GFP, used
here as a marker of caveolae and caveosomes (large green
structures seen in Fig. 5 B, which were never positive for PA;
note that fusion of GFP to the COOH terminus of caveo-
lin-1 does not lead to a dominant-negative phenotype; Pelk-
mans et al., 2001). Finally, to further rule out a caveolin-
mediated entry pathway and transport to caveosomes, we
found that intracellular SDS-resistant PA63 heptamers also
form in macrophages RAW264.7 and FRT cells; two cell types
that do not express caveolin-1 (Zurzolo et al., 1994; Kiss et al.,
2000; unpublished data), in agreement with the fact that mac-
rophages are sensitive to LF (Tang and Leppla, 1999).
As shown in Fig. 5 C, significant internalization of anti-
body-clustered PA
 
SNKE
 
 occurred within 5 min, and a simi-
larly short time was required to observe the SDS-resistant
PA63 heptamer (Fig. 5 D). Subsequent degradation of PA63
heptamers was apparent within 30 min (Fig. 5 D). These
rapid kinetics suggest that initial entry of PA might be clath-
rin-mediated. First, we investigated whether we could detect
clustered PA
 
SNKE
 
 in clathrin-coated structures by electron
microscopy, after warming the cells for 5 min at 37
 
 
 
C. As
shown in Fig. 5 E, gold particles could be detected both in
clathrin-coated pits and vesicles (Fig. 5 E, a–c) as well
as sometimes in nonclathrin-coated invaginations of the
plasma membrane (Fig. 5 E, d), but never in grape-like ca-
veosomes (not depicted). Next, we investigated whether
PA
 
SNKE
 
 was transported to endosomes. As shown in Fig. 5 F,
colocalization was found between intracellular PA
 
SNKE
 
 and
internalized transferrin (5 min), as well as internalized dex-
tran (15 min), indicating early endosomal localization. Next,
we investigated whether the GTPase dynamin was involved
in anthrax toxin uptake. Dynamin has been implicated in
both internalization of caveolae and in clathrin-mediated en-
docytosis (for review see McNiven et al., 2000). We made
use of a well-described HeLa cell line that can be induced to
express either wild-type dynamin-1 or a mutant defective in
Figure 3. Raft association of PA 
triggers cellular uptake. (A) Antibody 
cross-linking leads to the appearance 
of intracellular PA83. As schematized 
in the right panel, CHO cells were 
incubated for 20 min at 4 C with 
500 ng/ml PA
SNKE. Cells were then either 
(1) submitted to antibody cross-linking 
at 4 C and then further incubated at 
4 C (condition: X-link 4 C) or 37 C 
(condition: X-link 37 C) for 30 min or 
(2) incubated at 37 C for 30 min and 
then submitted to the antibody sandwich 
at 4 C (condition: 37 C X-link). For all 
conditions, cells were submitted or not 
to an acid wash before fixation. Bar, 10 
 m. (B) Cholesterol depletion inhibits 
intracellular accumulation of PA63. 
CHO cells were treated or not with 
 -MCD, then incubated for 20 min at 
4 C with 500 ng/ml PA
SNKE followed by 
an antibody sandwich (X-link 37 C). Internalization was allowed to proceed for 30 min at 37 C and cells were then submitted to a cold 
acid wash, fixed, and visualized using a fluorescent microscope.
Figure 4. Disruption of lipid rafts blocks formation of the PA 
channel and intracellular delivery of LF. (A) CHO cells were treated 
or not with  -MCD, incubated for 1 h at 4 C with 500 ng/ml trypsin-
nicked PA83, and were transferred to 37 C for different periods of 
time. Aliquots of 80  g total cell extract proteins were loaded on a 
7.5% SDS-gel and probed for PA by Western blotting. (B) CHO 
cells were treated or not with  -MCD, incubated for 1 h at 4 C with 
a mixture of 1  g/ml trypsin-nicked PA83 and 1  g/ml LF, and 
transferred to 37 C for different periods of time. 40  g of total cell 
extracts were analyzed by Western blotting (12.5% SDS-gel) for the 
presence of LF, total MEK1 (anti-COOH–terminal antibody), 
LF-processed MEK1 (anti-NH2–terminal antibody), and PA (using 
7.5% SDS-gels for the latter).T
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GTP binding and hydrolysis (Dyn
 
K44A
 
; Damke et al., 1994).
As shown in Fig. 5 G, appearance of the SDS-resistant PA63
heptamer was severely delayed in Dyn
 
K44A
 
-expressing cells
when compared with Dyn
 
WT
 
, as was the cleavage of MEK1
(unpublished data), showing that PA is preferentially inter-
nalized via a dynamin-dependent pathway. Because we have
excluded the caveolar uptake pathway, these results suggest
that clathrin is involved. To inhibit the clathrin-dependent
pathway more specifically, we overexpressed a dominant-
negative mutant of Eps15 (E
 
 
 
95/295), a protein required
for clathrin-mediated endocytosis that binds directly to the
plasma membrane adaptor AP2 (Benmerah et al., 1999).
Transient transfection of HeLa cells was performed using ei-
ther wild-type or dominant-negative Eps15 fused to GFP.
Transfection rates of 
 
 
 
75% were reached, and it was appar-
ent when measuring uptake of rhodamine transferrin that
very high expression levels of dominant-negative Eps15 (fol-
lowed by GFP fluorescence) were required to inhibit clath-
rin-mediated uptake (unpublished data); levels that were
reached in only few cells. Despite this, we have analyzed bio-
chemically the kinetics of appearance of the SDS-resistant
PA63 heptamer. As shown in Fig. 5 H, appearance of the
SDS-resistant heptamer was significantly delayed, as was the
subsequent degradation of the complex, even within this
population of HeLa cells with mixed levels of inhibition of
the clathrin pathway. Together, the inhibitory effects of
dominant-negative mutants of dynamin and Eps15 show
that the anthrax toxin preferentially enters the cell via a
clathrin-dependent pathway.
The behavior of ATR is reminiscent of that of the B cell
receptor, which undergoes ligand-dependent clustering and
raft association (Cheng et al., 1999), and is subsequently in-
ternalized via a clathrin-dependent mechanism (Stoddart et
al., 2002). Further studies will be required to determine
whether ATR moves laterally out of rafts before endocytosis
or, more likely, whether clathrin directly associates with
ATR-containing rafts as for the B cell receptor.
The physiological role of ATR, as well as that of its splic-
ing variant tumor endothelial marker 8 (St. Croix et al.,
2000), is unknown. However, the present work highlights
why anthrax toxin has highjacked this surface protein in par-
ticular. It indeed appears that independently of its function,
 
Figure 5. The anthrax toxin enters preferentially via a clathrin-
mediated pathway. (A) HeLa cells were transiently transfected with 
the dominant-negative caveolin-1 mutant (GFP-Cav1), incubated for 
1 h at 4 C with1  g/ml trypsin-nicked PA83, and transferred to 37 C 
for different periods of time. 40  g of total cell extracts were analyzed 
by Western blotting for the presence of heptameric PA63. (B) CHO 
cells were transiently transfected with caveolin-1-GFP (which has a 
wild-type phenotype), then incubated for 20 min at 4 C with 
500 ng/ml PA
SNKE followed by an antibody sandwich as in Fig. 3 
(X-link 37 C). Internalization was allowed to proceed for 30 min at 
37 C, and cells were then fixed and visualized using a fluorescent 
microscope. A blow-up of a region of the plasma membrane is 
shown. Bar, 10  m. (C) CHO cells were incubated for 20 min at 4 C 
with 500 ng/ml PA
SNKE followed by an antibody sandwich as in Fig. 
3 (X-link 37 C). Internalization was allowed to proceed for 0, 5, 
15, or 30 min at 37 C, cells were then submitted to a cold acid 
wash, fixed, and visualized. Bar, 10  m. (D) CHO cells were 
incubated for 1 h at 4 C with1  g/ml trypsin-nicked PA83, transferred 
to 37 C for different periods of time. 40  g of total cell extracts were 
analyzed by SDS-PAGE and Western blotting for the presence of 
SDS-resistant heptameric PA63. The band intensity was quantified 
by densitometry (expressed in arbitrary units, a.u.), and is shown as 
a histogram to clearly illustrate the appearance and the degradation 
of the heptamer. (E) Cells were treated as in C, then incubated with 
protein A coupled to 10 nm gold, fixed, and processed for embedding 
in Epon and sectioning. Three examples are shown on which the 
clathrin coat is clearly visible (a–c, arrows); d is an example showing 
PA
SNKE in an invagination with no apparent coat (arrowhead). 
Bar, 200 nm. (F) CHO cells were incubated for 20 min at 4 C with 
500 ng/ml PA
SNKE followed by an antibody sandwich (X-link 37 C). 
Internalization was allowed to proceed either for 5 min at 37 C in 
the presence of FITC-transferrin (Tf) or for 15 min in the presence 
of FITC-dextran. Cells were then submitted to a cold acid wash, 
fixed, and visualized. Examples of colocalization are indicated by 
arrowheads. Bar, 10  m. (G) HeLa cells induced to express either 
wild-type or K44A dominant-negative dynamin-1 were treated and 
analyzed as in A. Numbers below lanes represent the incubation 
times at 37 C in min. The band intensities were quantified and 
plotted as in C. (H) HeLa cells transiently transfected with wild-type 
or dominant-negative E 95/295 Eps15 mutant were treated and 
analyzed as in G.T
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ATR has a number of properties that make it the ideal an-
thrax toxin receptor. For a successful intoxication, PA re-
quires a receptor that keeps it at the cell surface as long as it
is monomeric, but drags it into the cell as soon as heptamer-
ization, with concomitant binding of LF and/or EF, has oc-
curred. Indeed, if on binding, PA83 were rapidly internal-
ized by the cell, processing by furin could still efficiently
occur in endosomes (Chapman and Munro, 1994), but
binding of extracellular LF and/or EF could never take
place, and the toxin would remain inactive. The initial sur-
face localization of ATR and its low endocytosis rate ensure
that cleavage by furin (which is also in the glycerophospholi-
pidic, nonraft region of the membrane; Abrami and van der
Goot, 1999) and heptamerization occur before uptake. The
ability of ATR to redistribute to lipid rafts and to then be
rapidly internalized via a clathrin-dependent mechanism on
clustering guarantees the intracellular delivery of the PA
heptamer–LF complex. This study clearly shows that subtle
changes in the surface distribution of ATR are crucial for its
function as an efficient anthrax toxin receptor, and might
also be required for its physiological function. Lipid rafts ap-
pear to play an important role in regulating the assembly
and the intracellular delivery of the anthrax toxin, and there-
fore constitute a potential therapeutic target.
Materials and methods
Reagents
Proteins produced as described previously (Leppla, 1988) include wild-
type PA, PA
SNKE (a non-furin cleavage variant of PA in which the furin
cleavage site was replaced by SNKE; Gordon et al., 1995), and LF. The
aerolysin mutant (ASSP) was obtained as described previously (Fivaz et al.,
2002). pAbs against PA (Liu et al., 2001) and LF were generated in the Lep-
pla lab (Liu and Leppla, 2003). Anti-COOH-terminal MEK1 antibodies
were obtained from Santa Cruz Biotechnology, Inc., anti-NH2-terminal
MEK1 antibodies obtained from Upstate Biotechnology, anti-caveolin-1
and anti-flotillin-1 mAbs were obtained from Transduction laboratories,
and FITC-conjugated secondary antibodies obtained from Molecular
Probes, Inc.  -MCD and filipin were obtained from Sigma-Aldrich.
Sphingomyelin-deficient (CHO SPB) and recomplemented (CHO
SPB(lcb1)) CHO cells were provided by K. Hanada (National Institute of
Infectious Diseases, Tokyo, Japan) and maintained as described previously
(Hanada et al., 1997). CHO PR230 is a previously described spontaneous
PA receptor–deficient mutant (Liu and Leppla, 2003). Transfection of CHO
PR230 with the ATR cDNA restored PA binding. Stable transfectants of
CHO PR230 were used expressing human ATR having an HA-tag at the
COOH terminus (Liu and Leppla, 2003). HeLa cell lines expressing wild-
type and K44A dynamin mutant were maintained as described previously
(Damke et al., 1994).
Biochemical methods
DRMs were prepared from CHO cells using OptiPrep gradients as de-
scribed previously (Lafont et al., 2002). 7–8 fractions were collected from
the top, the total protein content of each fraction was precipitated with 6%
TCA in the presence of 375  g sodium deoxylcholate as a carrier, and
were analyzed by SDS-PAGE. For Western blot analysis, gels were trans-
ferred onto a nitrocellulose membrane either using a semi-dry system or, in
order to detect the PA heptamer, by wet transfer for 5 h at 86 V.
Drug treatments
CHO cells were treated with 10 mM  -MCD or 1  g/ml filipin for 1 h at
37 C as described previously (Abrami and van der Goot, 1999). The
 -MCD treatment led to a 59.3   3.8% decrease in total cholesterol as
measured by one-dimensional TLC (Abrami and van der Goot, 1999).
Immunofluorescence
Coverslip-grown CHO cells were incubated with 500 ng/ml PA. Cell sur-
face–bound PA was submitted to clustering by an antibody sandwich. In
brief, cells were put on ice and incubated for 20 min with polyclonal anti-
PA antibodies followed by 20 min with secondary antibody FITC-anti–rab-
bit. To remove surface-bound antibodies, live cells were submitted to an
acid wash, i.e., incubated for 5 min at 23 C with 140 mM NaCl, 100 mM
citrate, pH 2.0. For all experiments, cells were fixed with 3% PFA and then
mounted on microscopy slides.
Electron microscopy
Cells were incubated with 1  g/ml PA
SNKE for 1 h at 4 C followed by a
sandwich of polyclonal anti-PA, mouse anti–rabbit IgG and 10-nm gold–
labeled protein A. Cells were then washed, shifted 5 min at 37 C, and
fixed with 2% glutaraldehyde in culture medium buffered with Hepes for
10 min at 37 C and with 2% glutaraldehyde in phosphate buffer for 30 min
at RT. After washes, the cells were pelleted in agar and incubated with 2%
osmium for 1 h at 4 C and overnight with 0.25% uranylacetate before deg-
radation and Epon embedding.
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